
HTQL is excited to share a new publication in Analytical Methods: “Development of an HPV16 rapid test founded in user-centered design with primary care clinicians.” This paper pairs a user-centered design process—with primary care clinicians informing early concept development and workflow needs—with detailed biomedical test specifications. By bridging user-centered design, clinical practice, and engineering, it

Our HTQLab undergrads, Jessica Nwokeji and Adeline Jolley, had recently presented at Purdue Undergraduate Research Expo (Fall 2025) about their research titled “Evaluating the Impact of Community Health Worker-Led Education on the Cervical Cancer Knowledge and Attitudes Seen in People Experiencing Homelessness“ They received great feedback and had a great time presenting insights. Great job!

Our lab is excited to spotlight Mrithula, who presented at the IAPHS 2025 Conference on breast and cervical cancer screening access. Her presentation, “Stakeholder Perspectives on Barriers and Facilitators to Breast and Cervical Cancer Screening among Hispanic Women in Indiana,” emphasized: This pilot project was part of a broader community assessment to identify barriers and

As we kick off this next year at HTQL, we’re taking a moment to celebrate the incredible achievements and milestones that made this past year special. Research and Community Impact We launched a study bringing CHW-led education and HPV self-sampling in homeless shelters, expanding access to screening. Two first-time first authors published new work by

Congratulations to Dr. Layla Claure for successfully defending her PhD thesis, Understanding Disparities in Cervical Cancer Screening among Hispanic Women in Indiana for Future Initiatives. As part of the inaugural PhD cohort in the Dept of Public Health at Purdue University, Layla’s leadership, mentorship of students, and dedication to uplifting community voices helped meaningfully shape

January is Cervical Cancer Awareness Month. People experiencing homelessness are up to four times more likely to be diagnosed with, or to die from, cervical cancer than those who are housed. This disparity is preventable. Cervical cancer is both preventable and treatable when caught early through screening. In our surveys and interviews with people experiencing

The FDA has recently approved HPV self-sampling tests, a groundbreaking development that promises to enhance accessibility and privacy in cervical cancer screening. While this is a huge step forward in cervical cancer prevention and care, there is still work to do to expand approval to non-clinic settings. At the Health TechQuity Lab, we have been

HTQL has hit the ground running with this semester! Connect with us and follow our conference journey as we dive into conversations about health disparities and solutions for change! Where you can find us:

Dr. Luke Brennan, a Purdue University graduate, has excelled in biomedical engineering research at HTQL, focusing on rapid diagnostic tools for HPV. He will now pursue further studies at IU School of Medicine.

Dr. Luke Brennan successfully defended his PhD in Biomedical Engineering and Public Health, and will now rejoin medical school at IU School of Medicine. Congratulations!